When:
September 23-25, 2012
Hyatt Regency Crystal City
Arlington, VA
Mission:
The diabetes epidemic demands a powerful response from leaders in the diabetes community, nationally and globally. By bringing together the best minds across payers, providers, industry, government, research, prevention and treatment, Diabetes Innovation 2012 will act as a powerful marketplace of ideas, partnerships and collaboration to provoke thought, innovation and action that address the cost, productivity and quality of life impact of diabetes on our society.
Diabetes Innovation 2012 will provide a powerful foundation for sustained focus and excitement for advancement in all facets of diabetes prevention, treatment and payment reforms –from social media and gaming to translational research breakthroughs to mobile patient technologies and everything in between.
The Diabetes Innovation 2012 and Joslin Diabetes center issues a challenge to key leaders to be the catalyst for new partnerships, practical and affordable solutions, and hope in our common goal of a future without diabetes, its complications and co morbidities—and with billions of dollars in savings.
Website:
For more information, and to register visit:
http://www.joslin.org/diabetesinnovation2012.html
Wednesday, August 29, 2012
Wednesday, August 1, 2012
What Makes Research Ethical?
August 8, 2012
12:00 pm - 1:00pm
Moore Auditorium, McDonnell Science Building
4565 McKinley Ave. St. Louis, MO 63110
Presented by:
Samuel Klein, MD, Danforth Professor of Medicine
"Metabolic Normal and Metabolically Abnormal Obesity"
Janet McGill, MD, Professor of Medicine
"6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine Lantus both plus Mealtime Insulin in Patients with Type 2 Diabetes Mellitus with a 6-month Safety Extension Period"
Jason Keune, MD, MBA, Ethics Certificate, Chief Resident in General Surgery, Article Highlights Ira Kodner, MD, Solon & Bettie Gershman Professor of Surgery, Program Facilitator
CNE will be awarded. Attendance at this session counts towards the RCR required educational training hours. Registration is required: http://hrpohome.wustl.edu/study_team/education/ethics_series.aspx.
12:00 pm - 1:00pm
Moore Auditorium, McDonnell Science Building
4565 McKinley Ave. St. Louis, MO 63110
Presented by:
Samuel Klein, MD, Danforth Professor of Medicine
"Metabolic Normal and Metabolically Abnormal Obesity"
Janet McGill, MD, Professor of Medicine
"6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine Lantus both plus Mealtime Insulin in Patients with Type 2 Diabetes Mellitus with a 6-month Safety Extension Period"
Jason Keune, MD, MBA, Ethics Certificate, Chief Resident in General Surgery, Article Highlights Ira Kodner, MD, Solon & Bettie Gershman Professor of Surgery, Program Facilitator
CNE will be awarded. Attendance at this session counts towards the RCR required educational training hours. Registration is required: http://hrpohome.wustl.edu/study_team/education/ethics_series.aspx.
Subscribe to:
Posts (Atom)